Actio Biosciences

Dublin, Ireland & San Diego, California, USA, August 10, 2026 Jazz Pharmaceuticals plc and Actio Biosciences, Inc. have announced...

SAN DIEGO, May 8, 2026 Actio Biosciences announced the initiation of the KYRON Phase 1b/2 clinical trial evaluating ABS-1230,...